VIR vs WDAY · rev $238.9M vs P/E 135, rev $5.19B
Vir Biotechnology Inc (VIR) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
VIR currently screens at market cap $1.45B. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the VIR and WDAY stock pages for the full models.
Not investment advice.